Hearts and Minds Investments Limited (ASX:HM1)
Hearts and Minds Investments Limited (ASX:HM1) is a unique listed investment company striving to deliver attractive equity investment returns for shareholders, while providing funding for Australian medical research. HM1 listed on the Australian Stock Exchange (ASX) on November 14, 2018. The fund was oversubscribed in just three days, raising $500 million across 5,500 shareholders.
Hearts and Minds’ esteemed collective of top-performing core fund managers generously share their highest conviction stock recommendations to the Company. Many of these funds are not accessible to retail investors, providing HM1 shareholders with an opportunity to benefit from those managers' highest conviction investment ideas. The unique blend of manager investment philosophies and styles aims to minimise the portfolio’s investment bias, and despite the relatively small number of securities (25-35), the portfolio has diversified exposure across multiple regions and sectors.
The company's charitable goal is made possible by waiving typical investment fees and instead, making a sizeable donation to its suite of medical research beneficiaries. The donation amount is a percentage of Net Tangible Asset value (NTA), which is published to market every week. It will create a growing and sustainable funding model for its beneficiaries. This would not be possible without the generous pro-bono commitment from the company's fund managers, key service providers and Board.